LeonaBio Inc
LONA
88 hedge funds and large institutions have $253M invested in LeonaBio Inc in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 15 closing their positions.
146% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 13
127% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 15
28% more funds holding
Funds holding: 69 → 88 (+19)
0.45% less ownership
Funds ownership: 7.1% → 6.65% (-0.45%)
48% less capital invested
Capital invested by funds: $484M → $253M (-$231M)
49% less call options, than puts
Call options by funds: $2.01M | Put options by funds: $3.94M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$17.5M |
| 2 |
BA
Bristlecone Advisors
Bellevue,
Washington
|
+$13.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.3M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$7.24M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$6.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$39M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$30.9M |
| 3 |
Janus Henderson Group
London,
|
-$15.9M |
| 4 |
RI
RTW Investments
New York
|
-$13M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$9.37M |
LONA Hedge Fund Activity: Q2 2021 in Review
88 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in LeonaBio Inc (LONA) for Q2 2021, worth a combined $253M — down 48% from $484M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new LONA positions and 15 closed out — a net gain of 19 holders — while 32 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock, adding an estimated $17.5M. The largest seller was Viking Global Investors, exiting entirely with an estimated $39M sold.
- 88 institutional investors held LeonaBio Inc (LONA) as of Q2 2021, up from 69 in Q1 2021.
- Funds reported $253M of LeonaBio Inc stock for Q2 2021, down 48% quarter-over-quarter.
- 34 funds opened new LeonaBio Inc positions in Q2 2021 and 15 closed out, a net change of +19 holders.
- The largest LeonaBio Inc buyer in Q2 2021 was BlackRock, an estimated $17.5M added.
- The largest LeonaBio Inc seller in Q2 2021 was Viking Global Investors, an estimated $39M sold.
Based on aggregated 13F filings for Q2 2021.